Valuation : Aoxing Pharmaceutical Company Inc

Market Cap 2.36Cr 2.04Cr 1.92Cr 1.75Cr 3.28Cr 224.21Cr 3.3Cr 23Cr 8.82Cr 114.05Cr 8.87Cr 8.68Cr 378.18Cr P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 4.22Cr 3.64Cr 3.42Cr 3.12Cr 5.86Cr 400.36Cr 5.9Cr 40Cr 16Cr 203.65Cr 16Cr 15Cr 675.28Cr EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
05/17/05 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
16/17/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/17/14 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/16/14 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/16/05 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/16/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/16/08 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/16/01 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/15/10 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/15/04 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/15/02 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/15/13 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/15/13 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
-28.29%-4.31% - - 10L
Average -28.29%
Weighted average by Cap. -28.29%

Financials

2015 2016
Net sales 2.55Cr 2.2Cr 2.07Cr 1.88Cr 3.54Cr 241.83Cr 3.56Cr 24Cr 9.51Cr 123.02Cr 9.57Cr 9.36Cr 407.9Cr 3.23Cr 2.79Cr 2.62Cr 2.39Cr 4.49Cr 306.83Cr 4.52Cr 31Cr 12Cr 156.08Cr 12Cr 12Cr 517.52Cr
Net income 54.95L 47.4L 44.58L 40.62L 76.38L 52Cr 76.79L 5.27Cr 2.05Cr 27Cr 2.06Cr 2.02Cr 88Cr 20.61L 17.78L 16.72L 15.24L 28.65L 20Cr 28.81L 1.98Cr 76.96L 9.95Cr 77.39L 75.71L 33Cr
Net Debt 2.48Cr 2.14Cr 2.01Cr 1.83Cr 3.45Cr 235.41Cr 3.47Cr 24Cr 9.26Cr 119.75Cr 9.31Cr 9.11Cr 397.06Cr 1.86Cr 1.6Cr 1.51Cr 1.37Cr 2.58Cr 176.14Cr 2.59Cr 18Cr 6.93Cr 90Cr 6.97Cr 6.82Cr 297.1Cr
Logo Aoxing Pharmaceutical Company Inc
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-